secwatch.observer — SEC 8-K summary
======================================

Issuer:     Natera, Inc. (NTRA)
CIK:        0001604821
Form:       8-K
Filed at:   2024-01-22T23:59:59+00:00
Accession:  0001104659-24-005384
Event type: m_and_a
Sentiment:  positive
Materiality: 0.65
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Natera acquires Invitae's prenatal and carrier screening assets for $10M upfront
--------------------------------------------------------------------------------

- Upfront cash payment of $10 million to Invitae for reproductive health assets.
- Additional potential milestone payments of $42.5 million, including cash and litigation-related credits.
- Invitae will transition its non-invasive prenatal screening and carrier screening customers to Natera.
- Acquisition expands Natera's cfDNA testing reach; CEO Steve Chapman cites commitment to service.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1604821/000110465924005384/0001104659-24-005384-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1604821/000110465924005384/tm243767d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-005384

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer